162 related articles for article (PubMed ID: 25247380)
1. Asymmetric synthesis of a CBI-based cyclic N-acyl O-amino phenol duocarmycin prodrug.
Uematsu M; Boger DL
J Org Chem; 2014 Oct; 79(20):9699-703. PubMed ID: 25247380
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI).
Lajiness JP; Boger DL
J Org Chem; 2011 Jan; 76(2):583-7. PubMed ID: 21192653
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of duocarmycin and CC-1065 analogues incorporating the 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]-3-azaindol-4-one (CBA) alkylation subunit.
Parrish JP; Kastrinsky DB; Hwang I; Boger DL
J Org Chem; 2003 Nov; 68(23):8984-90. PubMed ID: 14604371
[TBL] [Abstract][Full Text] [Related]
4. Effective asymmetric synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI).
Kastrinsky DB; Boger DL
J Org Chem; 2004 Apr; 69(7):2284-9. PubMed ID: 15049620
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of duocarmycin O-amino phenol prodrugs subject to tunable reductive activation.
Lajiness JP; Robertson WM; Dunwiddie I; Broward MA; Vielhauer GA; Weir SJ; Boger DL
J Med Chem; 2010 Nov; 53(21):7731-8. PubMed ID: 20942408
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
Boger DL; Hughes TV; Hedrick MP
J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
[TBL] [Abstract][Full Text] [Related]
8. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
Boger DL; Yun W; Han N
Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Properties of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Methoxy-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (MCBI) Alkylation Subunit: Magnitude of Electronic Effects on the Functional Reactivity.
Boger DL; McKie JA; Cai H; Cacciari B; Baraldi PG
J Org Chem; 1996 Mar; 61(5):1710-1729. PubMed ID: 11667041
[TBL] [Abstract][Full Text] [Related]
10. Efficacious cyclic N-acyl O-amino phenol duocarmycin prodrugs.
Wolfe AL; Duncan KK; Parelkar NK; Brown D; Vielhauer GA; Boger DL
J Med Chem; 2013 May; 56(10):4104-15. PubMed ID: 23627265
[TBL] [Abstract][Full Text] [Related]
11. Unexpected syntheses of seco-cyclopropyltetrahydroquinolines - from a radical 5-exo-trig cyclization reaction: analogs of CC-1065 and the duocarmycins.
Pati H; Howard T; Townes H; Lingerfelt B; McNulty L; Lee M
Molecules; 2004 Feb; 9(3):125-33. PubMed ID: 18007417
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins.
Boger DL; Brunette SR; Garbaccio RM
J Org Chem; 2001 Jul; 66(15):5163-73. PubMed ID: 11463270
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a cyclobutane duocarmycin derivative incorporating the 1,2,10,11-tetrahydro-9H-cyclobuta[c]benzo[e]indol-4-one (CbBI) alkylation subunit.
Lajiness JP; Boger DL
J Am Chem Soc; 2010 Oct; 132(39):13936-40. PubMed ID: 20839806
[TBL] [Abstract][Full Text] [Related]
14. Parallel synthesis and evaluation of 132 (+)-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins defining the contribution of the DNA-binding domain.
Boger DL; Schmitt HW; Fink BE; Hedrick MP
J Org Chem; 2001 Oct; 66(20):6654-61. PubMed ID: 11578217
[TBL] [Abstract][Full Text] [Related]
15. A unique class of duocarmycin and CC-1065 analogues subject to reductive activation.
Jin W; Trzupek JD; Rayl TJ; Broward MA; Vielhauer GA; Weir SJ; Hwang I; Boger DL
J Am Chem Soc; 2007 Dec; 129(49):15391-7. PubMed ID: 18020335
[TBL] [Abstract][Full Text] [Related]
16. Selective metal cation activation of a DNA alkylating agent: synthesis and evaluation of methyl 1,2,9, 9a-Tetrahydrocyclopropa[c]pyrido[3,2-e]indol-4-one-7-carboxylate (CPyI).
Boger DL; Boyce CW
J Org Chem; 2000 Jun; 65(13):4088-100. PubMed ID: 10866626
[TBL] [Abstract][Full Text] [Related]
17. Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Parrish JP; Kastrinsky DB; Stauffer F; Hedrick MP; Hwang I; Boger DL
Bioorg Med Chem; 2003 Aug; 11(17):3815-38. PubMed ID: 12901927
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective DNA alkylation by a pyrrole-imidazole S-CBI conjugate.
Bando T; Narita A; Asada K; Ayame H; Sugiyama H
J Am Chem Soc; 2004 Jul; 126(29):8948-55. PubMed ID: 15264825
[TBL] [Abstract][Full Text] [Related]
19. Initial development of a cytotoxic amino-seco-CBI warhead for delivery by prodrug systems.
Twum EA; Nathubhai A; Wood PJ; Lloyd MD; Thompson AS; Threadgill MD
Bioorg Med Chem; 2015 Jul; 23(13):3481-9. PubMed ID: 25963825
[TBL] [Abstract][Full Text] [Related]
20. A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct.
Wolfe AL; Duncan KK; Parelkar NK; Weir SJ; Vielhauer GA; Boger DL
J Med Chem; 2012 Jun; 55(12):5878-86. PubMed ID: 22650244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
